Primary Chemoradiotherapy Versus Primary Surgery for Non‐Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults
Head & Neck · 2026
DOI: 10.1002/hed.70319 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Head & Neck, 2026. Verfasst von Tian Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Eye, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Paranasal Sinus Neoplasms, Chemoradiotherapy. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objectives
Sinonasal rhabdomyosarcoma (SNRMS) is a rare malignancy with a poor prognosis. This study aimed to determine the optimal treatment modality for SNRMS. Materials and Methods Fifty‐five patients with SNRMS were treated at our institution between December 2012 and November 2022. Demographic characteristics, treatment information, and follow‐up data were collected and analyzed. The log‐rank tests were used to compare the differences between treatment groups, and overall survival (OS), progression‐free survival (PFS), local failure‐free survival (LFS), and distant metastasis‐free survival (DMFS) were estimated using the Kaplan–Meier method. Cox proportional hazards models were used to determine the factors associated with OS and PFS.
Results
The 2‐year OS, PFS, LFS, and DMFS rates were 55.6%, 46.5%, 51.9%, and 52.1%, respectively. Surgery was not associated with improved 2‐year OS (52.0% vs. 58.1%, p = 0.51), PFS (44.4% vs. 48.4%, p = 0.45), LFS (48.4% vs. 54.8%, p = 0.27), or DMFS (48.0% vs. 54.8%, p = 0.63) rates. Multivariate Cox regression analysis showed that primary chemoradiotherapy and intensity‐modulated radiotherapy (IMRT)/volumetric modulated arc radiotherapy (VMAT) independently predicted improved OS and PFS, and lack of response to induction chemotherapy (IC) independently was associated with poorer OS and PFS. Multivariate logistic regression analysis showed that IMRT/VMAT and primary chemoradiotherapy were the factors associated with a lower risk of local recurrence.
Conclusions
Primary chemoradiotherapy may represent the optimal treatment. Primary chemoradiotherapy, response to IC, and radiation technique were the independent prognostic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Eye, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.
- Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
- Department of Oncology, 920th Hospital of Joint Logistics Support Force, Kunming, China.
ORCID-Profile: Xinmao Song
Zitieren
APA
Wang, T., Huang, C., Li, Y., Tang, T., Xue, K., & Song, X. (2026). Primary Chemoradiotherapy Versus Primary Surgery for Non‐Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults. Head & Neck. https://doi.org/10.1002/hed.70319
Vancouver
Wang T, Huang C, Li Y, Tang T, Xue K, Song X. Primary Chemoradiotherapy Versus Primary Surgery for Non‐Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults. Head & Neck. 2026. doi:10.1002/hed.70319
BibTeX
@article{Wang2026,
author = {Wang, Tian and Huang, Chuang and Li, Yi and Tang, Tianci and Xue, Kai and Song, Xinmao},
title = {Primary Chemoradiotherapy Versus Primary Surgery for Non‐Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70319}
}
EUVIMED